India-based firm Lupin has joined the pegfilgrastim parade with the FDA’s approval of Armlupeg (pegfilgrastim-unne), the ...

Dr Pietro A. Canetta illustrates recent advances in IgA nephropathy and focal segmental glomerulosclerosis (FSGS) with two ...

Patients with endometriosis showed a 42% higher risk for self-harm, overdose, or suicide compared to matched controls, with ...

Urticaria updates from ACAAI 2025 include data on dupilumab for chronic urticaria, the relative effectiveness of 55 ...

Two ACR 2025 analyses link SGLT2 inhibitors to fewer RA flares and a lower risk for osteoarthritis than GLP-1 receptor ...

Mental health services in England remain overstretched and fragmented, MPs warn, as stalled funding decisions threaten to ...

Dermatologists long reluctant to tackle cutaneous lupus erythematosus may be more open to treating patients with approvals ...

The MHRA has approved tisotumab vedotin for adults with recurrent or metastatic cervical cancer, offering a new option after ...

Patients at primary care clinics received more dementia diagnoses after implementation of a machine-learning tool designed to ...

Two NEJM trials report conflicting results on long-term beta-blockers after MI in patients with preserved ejection fraction, ...

Women with obesity who discontinued GLP-1s were at increased risk for multiple adverse pregnancy outcomes than those who had ...

Clinicians say debunking misinformation in the exam room consumes valuable consultation time and often requires delicate, ...